FindTrial
Sign In

clinical efficacy of 30 and 60 Puta Naga Bhasma in the management of newly diagnosed Madhumeha

Comparative clinical efficacy of 30 and 60 Puta Naga Bhasma in the management of newly diagnosed Madhumeha (Type 2 Diabetes) and their anti-diabetic cell line study - NBM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030254
Enrollment
30
Registered
2021-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: and 60 Puta Naga Bhasma along with Sahapana of Nisha-Amalaki: Trial group 1: Patients will be treated with 30 Puta Naga Bhasma (62.5 mg) and Nisha (62.5 mg) + Amalaki Churna (62.5 mg) B

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both the sexes having age between 30 to 65 years. Patients having chief & associated complaints of Madhumeha. Newly diagnosed patients (who had not received any antidiabetic medicinal intervention or internal medicinal intervention for management of Madhumeha) of Madhumeha (Type 2 Diabetes) having chief & associated complaints (at least three among signs and symptoms- Prabhuta- Avilamutrata, Pipasadhikya, Kshudhadhikya). FBS- Level � 126 mg/dl and � 200 mg/dl and or PPBS- level � 200 mg/dl and � 300 mg/dl and or. Glycated haemoglobin �7% and �9%.

Exclusion criteria

Exclusion criteria: Age more than 65 and below 30 years. All patients of diabetes mellitus receiving insulin. All patients of diabetes mellitus receiving or received modern medicine as well as any other internal medicinal treatment. FBS- Level � 126 mg/dl and � 200 mg/dl PPBS- level � 200 mg/dl and � 300 mg/dl Glycated haemoglobin 9%. Malignant and accelerated systemic arterial hypertension. Other chronic debilitating diseases. Pregnant woman and planning to conceive within six months. Lactating mothers. Complications of diabetes: Non healing wound, end stage renal disease, systemic infection.

Design outcomes

Primary

MeasureTime frame
60 Puta Naga Bhasma is more effective than 30 Puta Naga Bhasma in the management of newly diagnosed patients of Madhumeha (Type 2 Diabetes).Timepoint: 04 month—

Secondary

MeasureTime frame
60 Puta Naga Bhasma and 30 Puta Naga Bhasma are effective in improvement in quality of life of patients of newly diagnosed MadhumehaTimepoint: 04 month—

Countries

India

Contacts

Public ContactBJ Patgiri

Institute for Post Graduate Teaching and Research in Ayurveda

patgiri124@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026